All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
Fostant 150mg Injection
Prescription Required
Salt Composition : Fosaprepitant Dimeglumine
Manufacturer : METTA LIFE SCIENCES PVT LTD
Origin of Medicine : India
1 Vial(s)
Introduction to Fostant 150mg Injection
Fostant 150mg Injection contains the active ingredient Fosaprepitant Dimeglumine. Fostant 150mg Injection is used to treat vomiting and nausea. It is commonly used to control the acute and delayed nausea and vomiting associated with cancer treatment, including high-dose cisplatin (highly emetogenic) and moderately nauseating cancer chemotherapy. The contraceptives fail to work efficaciously during the treatment with Fostant 150mg Injection.
Concomitant administration of warfarin significantly alters the blood clotting time, so it is necessary to monitor the patients on chronic warfarin therapy before initiating Fostant 150mg Injection. It is contraindicated in hypersensitive individuals. The dosage regimen includes the use of oral dexamethasone in the treatment. Inform your physician if you have any diseases. Inform your doctor if you are on warfarin therapy and contraceptive medication.
Uses of Fostant 150mg Injection
Fostant 150mg Injection is used in the treatment of the following:
- High emetogenic cancer chemotherapy
- Moderately emetogenic cancer chemotherapy
Therapeutic Effects of Fostant 150mg Injection
Fostant 150mg Injection works by acting on the receptors responsible for nausea and vomiting, antagonizing the substances involved.
Interaction of Fostant 150mg Injection with other drugs
Inform your doctor about any prescribed medications, over-the-counter medications, nutritional and vitamin supplements, or herbal products that you are taking or have taken before the treatment. Certain medications tend to interact with Fostant 150mg Injection and cause undesirable side effects.
More Information about Fostant 150mg Injection
- The vials should be stored between 2°-8° C.
How to consume Fostant 150mg Injection
Fostant 150mg Injection will be administered to you by a health care professional. Do not self-administer. Your doctor will decide your dose and duration of the therapy.
Safety Advices for Fostant 150mg Injection
Pregnancy
There are no established adverse effects of the Fostant 150mg Injection during the administration of pregnancy. It is advisable to take it only under specialist advice on necessary requirements. Consult your doctor about the potential risks of this medication.
Breast Feeding
There are no established adverse effects of the Fostant 150mg Injection during breastfeeding. Inform your physician if you are breastfeeding before taking this medicine.
Lungs
It is unknown whether Fostant 150mg Injection is safe when administered in lung failure patients. Please consult the doctor if you have any lung problems.
Liver
Fostant 150mg Injection should be used with caution in patients with severe liver disease. Dose adjustment may be needed. Please consult your doctor. No dose adjustment is recommended in patients with moderate to severe liver disease.
Alcohol
It is unsafe to consume alcohol with Fostant 150mg Injection. Please consult your doctor.
Driving
Fostant 150mg Injection may make you dizzy; avoid driving or handling heavy machines if you are unwell. Consult your physician for more advice.
Side Effects of Fostant 150mg Injection
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious side effects of Fostant 150mg Injection are:
- Skin blistering, peeling
- Low white blood cell count
- Anemia
- Severe allergic reaction
- Urinary tract infection
- Pain in extremity
- Abnormal physical weakness
- Nerve damage
Common side effects of Fostant 150mg Injection are:
- Fatigue
- constipation
- Indigestion, diarrhoea
- Rash, urticaria
- Loss of appetite
- hiccups
Word of Advice
Fostant 150mg Injection should be administered only by the doctor or nurse, and do not self-administer this injection. Inform the doctor if the patient has any history of allergic reactions, liver or kidney problems, and other medication taken for different medical conditions. Consult the doctor if the patient is planning for pregnancy or breastfeeding mother before taking this medication. Avoid driving and handling heavy machinery as it causes dizziness. Patients may feel a lack of concentration and alertness.
FAQs
Q 1. Is Fostant 150mg Injection a chemotherapy medication?
Fostant 150mg Injection is an antiemetic medication that prevents nausea and vomiting caused by chemotherapy (cancer treatment).
Q 2. Can Fostant 150mg Injection be given in children?
No, Fostant 150mg Injection is not recommended for children under six months of age or who weigh less than 6kg. Consult the doctor before taking Fostant 150mg Injectionn.
Q 3. Can Fostant 150mg Injection be given for liver disorders?
Fostant 150mg Injection is used with caution in severe liver disorders, and dosage adjustment is required. Consult the doctor before taking this medication.
Q 4. Can Fostant 150mg Injection be used in pregnancy?
No, Fostant 150mg Injection is not recommended in patients during pregnancy or who are planning for pregnancy as it causes harmful effects on the developing baby.
Q 5. Can I drink while using Fostant 150mg Injection?
It is unsafe to use Fostant 150mg Injection while consuming alcohol because it reduces the effectiveness of the medicine.
Q 6. Can I drive after usingFostant 150mg Injection?
No, avoid driving, as Fostant 150mg Injection can cause dizziness. Patients may lack concentration and alertness.
Fact Box of Fostant 150mg Injection
| Molecule Name: Fosaprepitant Dimeglumine | Therapeutic Class: Antiemetic |
| Pharmacological Class: Neurokinin-1 Receptor Antagonist | Indications: To prevent nausea and vomiting due to chemotherapy. |
References
1. KD Tripathi, Essentials of Medical Pharmacology, Antiemetic, Prokinetic and Digestant Drugs, 7th edition, 2013, 669-670.
2. Merck Sharp & Dohme Corp, US Food and Drug Administration, [Revised date Feb 2016], [Accessed date 2nd April 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022023s014lbl.pdf
3. National Cancer Institute, [Accessed date 2nd April 2021], https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fosaprepitant-dimeglumine
Disclaimer
MrMed’s primary intention is to ensure that its consumers get accurate and trustworthy information that is reviewed by experts. The contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
